Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Accounts Receivables Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Accounts Receivables
$36.5m
CAGR 3-Years
55%
CAGR 5-Years
136%
CAGR 10-Years
80%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Accounts Receivables
$10.3m
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
59%
Repare Therapeutics Inc
NASDAQ:RPTX
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Accounts Receivables
CA$6.1m
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
20%
Spectral Medical Inc
TSX:EDT
Accounts Receivables
CA$337k
CAGR 3-Years
-16%
CAGR 5-Years
2%
CAGR 10-Years
-6%

See Also

What is Aurinia Pharmaceuticals Inc's Accounts Receivables?
Accounts Receivables
36.5m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Accounts Receivables amounts to 36.5m USD.

What is Aurinia Pharmaceuticals Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
80%

Over the last year, the Accounts Receivables growth was -4%. The average annual Accounts Receivables growth rates for Aurinia Pharmaceuticals Inc have been 55% over the past three years , 136% over the past five years , and 80% over the past ten years .

Back to Top